The American Medical Association Oct. 6 announced Current Procedural Terminology code set updates to now include vaccine and administration codes for pediatric doses of the Pfizer COVID-19 vaccine. The provisional codes will be effective upon the Food and Drug Administration issuing emergency use authorization for the vaccine’s use for children ages five to 11. The AMA published the code last week in advance of the FDA’s approval to ensure hospitals and health systems are prepared when the EUA is approved.

Related News Articles

Headline
The Centers for Disease Control and Prevention yesterday released an operational planning guide for pediatric COVID-19 vaccination and preliminary information…
Headline
Available data support the safety and effectiveness of the Johnson & Johnson COVID-19 vaccine for emergency use authorization as a booster dose in…
Headline
A Food and Drug Administration advisory panel today voted unanimously to recommend an extra Moderna booster dose for certain individuals. The Vaccines and…
Headline
The AHA today launched a new video series, Vaccines Work, highlighting all the successful vaccines that have helped fight severe disease and illness, such as…
Headline
A new study released today by the National Academies of Sciences, Engineering and Medicine offers advice for communicating with parents about their children’s…
Headline
Food and Drug Administration staff provided their analysis of Johnson & Johnson’s COVID-19 booster application today, indicating that a second dose…